skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Medicin Och Hälsovetenskap remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

Bostner, Josefine ; Karlsson, Elin ; Pandiyan, Muneeswaran J. ; Westman, Hanna ; Skoog, Lambert ; Fornander, Tommy ; Nordenskjöld, Bo ; Stål, Olle

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.397-406 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
2
ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

Manna, Subrata ; Bostner, Josefine ; Sun, Yang ; Miller, Lance D ; Alayev, Anya ; Schwartz, Naomi S ; Lager, Elin ; Fornander, Tommy ; Nordenskjöld, Bo ; Yu, Jane J ; Stål, Olle ; Holz, Marina K

Clinical cancer research, 2016-03, Vol.22 (6), p.1421-1431 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

Karlsson, Elin ; Pérez-Tenorio, Gizeh ; Amin, Risul ; Bostner, Josefine ; Skoog, Lambert ; Fornander, Tommy ; Sgroi, Dennis C ; Nordenskjöld, Bo ; Hallbeck, Anna-Lotta ; Stål, Olle

Breast cancer research : BCR, 2013-01, Vol.15 (5), p.R96-R96, Article R96 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer

Karlsson, Elin ; Veenstra, Cynthia ; Emin, Shad ; Dutta, Chhanda ; Pérez-Tenorio, Gizeh ; Nordenskjöld, Bo ; Fornander, Tommy ; Stål, Olle

Breast cancer research and treatment, 2015-08, Vol.153 (1), p.31-40 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
5
PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer
PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer

Karlsson, Elin ; Veenstra, Cynthia ; Gårsjö, Jon ; Nordenskjöld, Bo ; Fornander, Tommy ; Stål, Olle

Journal of cancer research and clinical oncology, 2019-03, Vol.145 (3), p.599-607 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
6
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype
Material Type:
Artigo 		Adicionar ao Meu Espaço

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype

Veenstra, Cynthia ; Karlsson, Elin ; Mirwani, Sanam Mirwani ; Nordenskjöld, Bo ; Fornander, Tommy ; Pérez-Tenorio, Gizeh ; Stål, Olle

Journal of cancer research and clinical oncology, 2019-07, Vol.145 (7), p.1845-1856 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts
S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts
Material Type:
Artigo 		Adicionar ao Meu Espaço

S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts

Bostner, Josefine ; Karlsson, Elin ; Eding, Cecilia Bivik ; Perez-Tenorio, Gizeh ; Franzén, Hanna ; Konstantinell, Aelita ; Fornander, Tommy ; Nordenskjöld, Bo ; Stål, Olle

Endocrine-related cancer, 2015-06, Vol.22 (3), p.331-343 [Periódico revisado por pares]

England: Bioscientifica Ltd

Texto completo disponível

Citações Citado por
8
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer

Pérez-Tenorio, Gizeh ; Karlsson, Elin ; Waltersson, Marie Ahnström ; Olsson, Birgit ; Holmlund, Birgitta ; Nordenskjöld, Bo ; Fornander, Tommy ; Skoog, Lambert ; Stål, Olle

Breast cancer research and treatment, 2011-08, Vol.128 (3), p.713-723 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
9
Met and its ligand HGF are associated with clinical outcome in breast cancer
Met and its ligand HGF are associated with clinical outcome in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Met and its ligand HGF are associated with clinical outcome in breast cancer

Veenstra, Cynthia ; Pérez-Tenorio, Gizeh ; Stelling, Anna ; Karlsson, Elin ; Mirwani, Sanam Mirwani ; Nordensköljd, Bo ; Fornander, Tommy ; Stål, Olle

Oncotarget, 2016-06, Vol.7 (24), p.37145-37159

United States: Impact Journals LLC

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (8)

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.